FDA advisors vote against effectiveness of Biogen’s ALS drug for… A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S.,… Read More...
FDA advisors reject Biogen’s ALS drug for rare and aggressive… A pedestrian walks past Biogen Inc. headquarters in Cambridge, Massachusetts, U.S.,… Read More...
FDA staff says Biogen’s ALS drug may have a ‘clinical… U.S. Food and Drug Administration staff on Monday said Biogen's investigational ALS… Read More...
FDA will review Eisai’s and Biogen’s Alzheimer’s… Andrew Brookes | Image Source | Getty ImagesThe Food and Drug Administration will… Read More...
Biogen’s C.E.O. will step down following disastrous launch of… Biogen said on Tuesday that it will replace its chief executive and effectively give… Read More...
Why Biogen’s Alzheimer’s drug Aduhelm is so controversial The U.S. Food and Drug Administration's approval of Biogen's Alzheimer's drug Aduhelm… Read More...
Biogen’s Alzheimer’s drug is unlikely to win E.U. approval. The drug maker Biogen said on Wednesday that a panel of drug reviewers in the… Read More...